June 29, 2009

A potent and selective anti-tumor agent on human gastric cancer

A research article to be published on June 21, 2009 in the World Journal of Gastroenterology addresses this question. The research team led by Professor Yan Li from Shengjing Hospital of China Medical University studied the growth inhibitory effects of Alisol B acetat and determined its mechanism of antitumor activity in human gastric cancer cell line SGC7901.

Professor Li and his colleagues found that Alisol B acetat could inhibit the proliferation of SGC7901 cell in a time and dose dependent manner. Among the various phases of cell cycle, the percentage of cells in S phase was significantly decreased, while the percentage of cells in G1 phase was increased. Flow cytometry assay also showed Alisol B acetate had positive effect on apoptosis. Typical apoptotic morphology such as condensation and fragmentation of nuclei and formation of apoptotic bodies could be observed through electron microscope and phase-contrast microscope. Further investigating the molecular mechanism behind Alisol B acetat -induced apoptosis, cells treated with Alisol B acetat underwent a rapid loss of mitochondrial transmembrane potential, activition of caspase-3, -9, upregulation of Apaf-1 and Bax, and inhibition of the PI3K/Akt in a time-dependent manner.

The researches domenstrated for the first time that Alisol B acetate induced human gastric cancer apoptosis through regulation of mitochondrial and PI3K/AKT signaling pathways Their research results indicate that Alisol B acetate might be used to treat gastric cancer , one of the most common cancers worldwide. By knowing the mechanism of action of Alisol B acetate, it may provide a new therapeutic option, as a potential anticancer agent, in the treatment of .

More information: Xu YH, Zhao LJ, Li Y. Alisol B acetate induces apoptosis of SGC7901 cells via mitochondrial and phosphatidylinositol 3-kinases/Akt signaling pathways. World J Gastroenterol 2009; 15(23): 2870-2877. www.wjgnet.com/1007-9327/15/2870.asp

Source: (news : web)

Citation: A potent and selective anti-tumor agent on human gastric cancer (2009, June 29) retrieved 25 April 2024 from https://medicalxpress.com/news/2009-06-potent-anti-tumor-agent-human-gastric.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

A potent and selective anti-tumor agent on human gastric adenocarcinoma
 shares

Feedback to editors
How immune cells communicate to fight viruses: New mouse model enables identification of chemokine producers and sensors

48 minutes ago
Differentiating cerebral cortical neurons to decipher molecular mechanisms of neurodegeneration

57 minutes ago
National trial safely scales back prescribing of a powerful antipsychotic for the elderly

1 hour ago
With hybrid brains, these mice smell like a rat

1 hour ago
Premature mortality higher among sexual minority women, study finds

1 hour ago
Creatine found to improve cognitive performance during sleep deprivation

1 hour ago
Identifying a new liver defender: The role of resident macrophages

1 hour ago
Researchers create an AI-powered digital imaging system to speed up cancer biopsy results

2 hours ago
Understanding the cellular mechanisms of obesity-induced inflammation and metabolic dysfunction

2 hours ago
Researchers publish final results of key clinical trial for gene therapy for sickle cell disease

2 hours ago
Load comments (1)